secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apimeds Pharmaceuticals US, Inc. (APUS)
CIK:        0001894525
Form:       8-K
Filed at:   2025-10-16T23:59:59+00:00
Accession:  0001213900-25-099553
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apimeds Pharmaceuticals amends bylaws to allow shareholder action by written consent
--------------------------------------------------------------------------------

- Board adopted First Amendment to Bylaws on October 15, 2025, effective immediately.
- Amendment permits shareholders to take action by written consent without a meeting.
- Change provides shareholders an additional mechanism to act outside of annual or special meetings.
- No other changes to the bylaws were made; full amendment filed as Exhibit 3.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/0001213900-25-099553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/ea0261543-8k_apimeds.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-099553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer